Watanabe N, Matsuda S, Kuramochi S, Tsuzuku J, Yamamoto T, Endo K
Department of Nuclear Medicine, Gunma University School of Medicine, Maebashi.
Jpn J Clin Oncol. 1995 Feb;25(1):5-9.
C-terminal src kinase (CSK) is a cytoplasmic protein which decreases activities of the Src family protein-tyrosine kinases. We produced a polyclonal antibody specific for CSK and analyzed the expression of CSK by immunoblotting in two human colorectal normal cell lines and eighteen cancer cell lines. CSK was detected in both the two normal and all the eighteen cancer cell lines. The expression of CSK obtained from human colorectal cancer cell lines was greater than that from human colorectal normal cell lines in most cases. The elevated expression of CSK in human colorectal cancer cell lines appeared to correspond to the elevated p60c-src (c-Src) and p62c-yes (c-Yes) protein-tyrosine kinase activities found in other studies. Thus, CSK may not have an anti-oncogenic role to play through the negative regulation of Src family kinases in colorectal carcinogenesis.
C端Src激酶(CSK)是一种细胞质蛋白,可降低Src家族蛋白酪氨酸激酶的活性。我们制备了一种对CSK具有特异性的多克隆抗体,并通过免疫印迹法分析了两种人结肠直肠正常细胞系和18种癌细胞系中CSK的表达情况。在两种正常细胞系和所有18种癌细胞系中均检测到了CSK。在大多数情况下,人结肠直肠癌细胞系中CSK的表达高于人结肠直肠正常细胞系。人结肠直肠癌细胞系中CSK表达的升高似乎与其他研究中发现的p60c-src(c-Src)和p62c-yes(c-Yes)蛋白酪氨酸激酶活性的升高相对应。因此,在结肠直肠癌发生过程中,CSK可能无法通过对Src家族激酶的负调控发挥抗癌作用。